GO
Loading...

Eli Lilly and Co

More

  • Double In A Decade Tuesday, 26 Feb 2008 | 6:21 PM ET

    Healthcare spending is expected to nearly double to $4.3 trillion by 2017. Who’s most likely to benefit and can you trade it?

  • Pfizer's CEO Kindler Being Kind To Hillary--Again Monday, 25 Feb 2008 | 1:37 PM ET

    According to The Center for Responsive Politics' web site Pfizer Chairman and CEO Jeff Kindler has opened his wallet again for Sen. Hillary Clinton. You can see his latest "give" here. Twice now within the past year Kindler has given the maximum amount ($2,300) an individual can contribute to a candidate.

  • Surprise Friday Friday, 15 Feb 2008 | 6:57 PM ET

    A top industry insider gives us the dish on a story of the week. Get the details now!

  • Stocks Up for the Week Despite Holiday Sell-Off Friday, 15 Feb 2008 | 5:18 PM ET

    Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Recession Worries Spur Sell-Off Ahead of Holiday Friday, 15 Feb 2008 | 2:32 PM ET

    Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Data, Best Buy Spook Stocks Ahead of Holiday Friday, 15 Feb 2008 | 11:30 AM ET

    Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Data, Best Buy Spook Stocks Ahead of Holiday Friday, 15 Feb 2008 | 10:54 AM ET

    Investors usually cash out ahead of a holiday weekend and, in this jittery environment, they found their reasons to sell today: a slew of bleak economic reports and a profit warning from Best Buy.

  • Pfizer and High Yielding Healthcare Wednesday, 13 Feb 2008 | 1:04 PM ET

    With a 5.6% dividend yield, Pfizer is currently the highest yielding stock in the Dow Jones Industrial Average and ranks 20th in yield on the S&P 500.  As a point of comparison, 30 Yr treasuries and the Lehman Aggregate Bond Index are yielding about 4.5%.  The Lehman Corporate Bond Index is yielding 5.55%. So is it the time to buy PFE?

  • Recession Fears Knock Stocks Monday, 4 Feb 2008 | 6:23 PM ET

    Stocks lost ground Monday, coming off their best week in nearly five years. What's the word on the Street?

  • Bernanke Fails to Boost Banks Wednesday, 30 Jan 2008 | 7:25 PM ET

    The Dow gives up a 200-point gain as traders second guess the Fed decision. Fast Money offers some clarity on the future - as well as a ton of after-hours action - in the Word on the Street.

  • Lilly in Settlement Talks With Government Wednesday, 30 Jan 2008 | 4:59 PM ET
    Eli Lilly's drug Zyprexa.

    abstract goes here

  • Eli Lilly Prez: EPS Will Soar 'Til 2011 Tuesday, 29 Jan 2008 | 11:50 AM ET

    Eli Lilly posted a higher fourth-quarter profit Tuesday. The pharmaceutical firm cited lower taxes and better-than-expected drug sales -- especially sales of its newer formulations for diabetes and cancer. John Lechleiter, president and chief operating officer -- and Lilly's CEO as of April 1 -- gave CNBC his strong earnings outlook.

  • Lilly & Amylin's Byetta Ad Buys Don't Pay Off Tuesday, 29 Jan 2008 | 10:27 AM ET
    Byetta Needle

    Direct-to-consumer pharmaceutical advertising is everywhere in American media because it works. Generally speaking, it drives patients to ask/tell their doctors to prescribe a particular medication.

  • Lilly Profit Rises on Demand for Newer Drugs Tuesday, 29 Jan 2008 | 9:24 AM ET

    Eli Lilly Tuesday said fourth-quarter profit rose on lower taxes and better-than-expected sales of its medicines, including its newer treatments for depression, diabetes and cancer.

  • Eli Lilly CEO: Pharma Safe From Markets & Politics Friday, 25 Jan 2008 | 11:40 AM ET

    Despite recent market upheavals, Sidney Taurel, CEO of Eli Lilly, says he is not convinced the pharmaceuticals sector will be negatively impacted. “The pharmaceutical industry is not that affected by business cycles, and so I believe this financial and possible economic crisis isn’t going to affect significantly our company or the industry.”

  • Ladies' Night Web Extra: Part 1 Wednesday, 23 Jan 2008 | 2:24 PM ET

    The show was over, but Cramer kept going. Don't miss his in-depth answers to audience questions about Merck, Target and more.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Pharma Analyst: Stocks Healthy Despite Bad News Thursday, 17 Jan 2008 | 3:55 PM ET
    Eli Lilly

    For the second time this week, big pharma is taking a beating from critical reports about medications. This time, it's antidepressants. But one analyst thinks the drag on shares is overdone -- and names "exciting" pharma stocks.

  • Pharma Investors: Will Political Talk Scare Them Off? Thursday, 17 Jan 2008 | 10:32 AM ET

    If or when you watch one of the presidential  debates count how many times the candidates say, "the drug companies." Of course, it depends on which party's debate you might be watching, but since I started paying attention to the race in recent weeks, I've taken notice how much those three words seem to be apart of boilerplate answers and statements...

  • Novo Nordisk: A Big "No" To Inhaled Insulin--For Now Tuesday, 15 Jan 2008 | 8:11 AM ET

    In the wake of Pfizer pulling the plug on its poor-selling inhaled insulin Exubera, the world's biggest diabetes drug company, Novo Nordisk is throwing in the towel on development of its version of inhaled insulin.

  • Eli Lilly

    Even though I'm back on the East Coast today I wanted to share what I think is an interesting anecdote from my time Monday at the JPMorgan Healthcare Conference which is wrapping up in San Francisco.